HedgeChatter

  • Home /
  • Tag Archives

OPXA

Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results

[Business Wire] – Opexa Therapeutics, Inc. , a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis , today announced that the Company will report financial results for the three months ended Mar moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, […]

May 12, 2014 Bystocknews , Comments Off on Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results read more

Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update

[Business Wire] – Opexa Therapeutics, Inc. , a biotechnology company developing a novel T-cell immunotherapy for multiple sclerosis , today reported financial results for the year moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update read more

Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results

[Business Wire] – Opexa Therapeutics, Inc. , a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis , today announced that the Company will report financial results for the year ended December 31 moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, […]

February 26, 2014 Bystocknews , Comments Off on Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results read more

Will Opexa Become A Multi-Bagger?

moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, click here to view […]

February 21, 2014 Bystocknews , Comments Off on Will Opexa Become A Multi-Bagger? read more

Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference

[Business Wire] – Opexa Therapeutics, Inc. , a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis , today announced that Neil K. moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, click here to view […]

February 11, 2014 Bystocknews , Comments Off on Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference read more

04/01/2013 – Opexa Therapeutics Announces Changes to Senior Management Team

[at noodls] – Opexa Therapeutics Announces Changes to Senior Management Team THE WOODLANDS, Texas (April 01, 2013) – Opexa Therapeutics, Inc. (NASDAQ: OPXA), a leader in developing a patient specific T-cell immunotherapy … moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, click here to view […]

April 1, 2013 Bystocknews , Comments Off on 04/01/2013 – Opexa Therapeutics Announces Changes to Senior Management Team read more

03/28/2013 – Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update

[at noodls] – Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update THE WOODLANDS, Texas (March 28, 2013) – Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing … moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, click here to view […]

April 1, 2013 Bystocknews , Comments Off on 03/28/2013 – Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update read more

The Vatican’s Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference

[at noodls] – Highlights Include Keynote by Nobel Prize Winner, Dr. John Gurdon New York, March 21, 2013 — The Stem for Life Foundation, NeoStem, Inc. (NYSE MKT:NBS), The Pontifical Council for Culture, and STOQ International … moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, click […]

March 22, 2013 Bystocknews , Comments Off on The Vatican’s Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference read more

03/04/2013 – Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum

[at noodls] – Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum THE WOODLANDS, Texas (March 4, 2013) – Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelnaâ„¢, a novel T-cell … moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboardSee who Opexa is hiring next, click here to […]

March 4, 2013 Bystocknews , Comments Off on 03/04/2013 – Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum read more